|
Market Cap (3-Jul) $617,674,048 (1,200th) |
Close (30-Jun) $0.130 |
Volume (30-Jun) 13,196,801 |
Shortsold (19-Jun) 70,661,833 (3.60%) (67th) |
|
52w High $0.54 |
52w Low $0.283 |
P/E - |
EPS -0.02 |
BOT released this announcement to the ASX on 4 May 2021, 9:01. The announcement is marked as price sensitive, and is 21 page(s) in length and 4.66MB in size.
You can view all announcements from BOT and see how they appear on a price chart on the announcements page.
At the date of this announcement, BOT was 0.141% short sold according to ASIC data. It was ranked the 415th most shorted stock on the ASX. It is now ranked as the 67th most shorted stock on the ASX with 3.604% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from BOT | |
|---|---|
| Section 708A(5)(e) Notice | 27 June 2023, 19:11 |
| Application for quotation of securities - BOT | 27 June 2023, 19:07 |
| Section 708A(5)(e) Notice | 15 June 2023, 14:07 |
| Botanix Update on BTX 1801 Clinical Development | 4 May 2021, 9:01 |
| Appendix 4C - Quarterly | 30 April 2021, 9:34 |
| Publication and Awareness boosts BOT Antimicrobial Platform | 27 April 2021, 8:31 |
| BTX 1702 Rosacea Study Approval | 30 March 2021, 9:19 |
You must be logged in to post a reply.
Botanix Pharmaceuticals 